-+ 0.00%
-+ 0.00%
-+ 0.00%

VivoSim Labs Signs JCBio As Authorized Distributor In Korea, Tekon Biotech In China For NAMKind Toxicology Services In Liver, Small Intestine

Benzinga·01/29/2026 21:10:48
Listen to the news

VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced it has signed JCBio as an authorized distributor in Korea and Tekon Biotech as an authorized distributor in China for its NAMKind™ toxicology services in liver and small intestine. The appointments expand VivoSim's commercial presence across Asia-Pacific, which potentially provides faster access to human-relevant toxicology services for pharmaceutical and biotechnology organizations facing growing pressure to de-risk programs earlier and accelerate timelines.